MARKET OVERVIEW- NORTH AMERICA DRUG TESTING MARKET
A drug test involves testing a biological sample, such as urine or hair, for the presence of legal or illegal drug. The drug testing are used to ascertain whether or not a person is currently or has ever been under the influence of drugs. New technology has been introduced, giving users precise and accurate results. The increase in alcohol consumption among young and old, the excessive use of prescription drugs, the increase in the consumption of narcotics and illicit drugs are some of the key and important drivers for the market. In order to decrease the consumption of the addictive drugs, strict regulations have widely imposed all over the world. Due to these factors, the market is expected to grow tremendously over the forecast period.
MARKET DRIVERS
The primary factors driving market growth is the rising consumption of alcohol by young people and the elderly, the overuse of prescribed medications, and the rise in opioid and illicit drug use. The growing drug abuse and alcohol consumption are increasing in the region, which is expected to drive market growth. For instance, in 2021, according to the report, 60% of U.S. adults drank alcoholic beverage. The high consumption of alcoholic beverage among the Mexican population is also driving the market growth. For instance, Mexican went from consuming 130.7 beer cans per capita in 2020 to 183.9 beer cans in 2021, a 41% increase in beer consumption, according to National institute of Statistics and Geography Data. Further, the increased illegal drug usage and rising crime rates related to drug addiction are expected to drive the demand for drug testing.
MARKET OPPORTUNITIES
In addition to rising government funding in key markets, regulatory approvals of new products and services, surges in funding for drug testing, and increased awareness of drug abuse are among the key factors propelling the drug testing market. The enforcement of strict laws requiring drug and alcohol testing is a crucial factor in escalating market growth. The United States Department of Transportation (DOT), which is in charge of assisting in the safety of air travel, commercial motor vehicles, railroad transportation, mass transit, hazardous materials, and maritime business, began requiring drug testing of federally regulated, safety-sensitive employees working in these areas. The enforcement of strict laws requiring drug and alcohol testing is a crucial factor in escalating market growth.
MARKET RESTRAINTS
The rising ban on alcohol consumption in these countries and the prohibition of workplace drug testing in some countries are the major factors among others which will obstruct the market growth.
MARKET GROWTH CHALLENGES
Further, the rising accuracy and specificity concerns related to breathalysers will further challenge the growth of drug testing market. Also, a key challenge that may affect the growth of the market is lack of skilled work force among the healthcare sector in underdeveloped nations is expected to be major challenge for the market growth over the forecast the period.
CUMULATIVE GROWTH ANALYSIS
The report provides in-depth analysis of North America drug testing market, market size, and compound annual growth rate (CAGR) for the forecast period of 2023-2029, considering 2022 as the base year. The increasing demand for various Drug Testing Services in various substance and drug abuse applications has led to increasing demand for market and is expected to witness the growth at a specific CAGR from 2023-2029.
DRUG TESTING MARKET SEGMENTAL OVERVIEW
The North America Drug Testing market comprises of different market segment like products, sample type, drug type, end-users and country.
NORTH AMERICA DRUG TESTING MARKET BY PRODUCTS AND SERVICES
By products and services, the Drug Testing Market includes the key segment like
- Consumables
- Instruments
- Rapid Testing Devices
- Laboratory Services
The consumables segment is anticipated to dominate the market over the projected time period. The increasing introduction of advanced consumables that provide improved solutions to make testing, simple, accurate, and fast expected to accelerate market growth. For instance, in August 2019, MedTest Dx, Inc. introduced Clinitox Calibrators and Controls at the 2019 American Association for Clinical Chemistry (AACC) Annual Scientific Meeting. These calibrators and controls perform confirmation testing for laboratories to eliminate measurement of steps and manage controls and certifications, need to acquire and set-up materials, and multiple handling.
Furthermore, the laboratory services segment is expected to witness high growth over the forecast period. An increase in strategic initiatives being undertaken by various companies such as acquisitions, collaborations, and partnerships to support public safety and government agencies has propelled the segmental growth.
NORTH AMERICA DRUG TESTING MARKET BY SAMPLE TYPE
By sample type, the Drug Testing Market includes the key segment of
- Urine
- Breath
- Oral Fluid
- Hair
The urine sample segment is anticipated to dominate the market over the projected time period. This rapid growth can be attributed to the fact that urine samples are the most frequent sample type used to test for the presence of illicit drugs. To produce a false-negative test result, adulteration is now a common occurrence in urine samples, which can have a negative effect on market expansion.
On the other hand, the oral fluid segment is expected to witness high growth over the forecast period. It is a quicker and less invasive sample to collect at the roadside. Oral fluid sample are preferred over urine samples due to their ability to save time and preserve dignity, regardless of the additional costs, according to NCBI 2020 study, which was based on a survey of both staff and patients.
NORTH AMERICA DRUG TESTING MARKET BY DRUG TYPE
By drug type, the Drug Testing Market includes the key segment of
- Alcohol
- Cocaine
- Opioids,
- Amphetamine and Methamphetamine
- Cannabis/Marijuana
- LSD
The cannabis/ marijuana segment is anticipated to dominate the market over the projected time period. Cannabis/marijuana, is the most widely used illicit substance in important markets, and as a result, testing kits and equipment are in high demand. The most widely used illicit drug in the U.S. in 2018 was marijuana, according to the Substance Abuse and Mental Health Services Administration. S. marijuana, which was used by about 431.5 million people. These factors are expected to drive the segment’s growth.
NORTH AMERICA DRUG TESTING MARKET BY END-USER
By end-user, the Drug Testing Market includes the key segment of
- Drug Testing Laboratories
- Workplaces
- Hospitals
- Drug Treatment Centers
- Individual Users
- Criminal Justice Systems and Law Enforcement Agencies
- Pain Management Centers
- Pain Management Centers
The drug testing laboratories segment dominated the market. Drug testing laboratories can detect the presence of nay illicit substance. The accessibility of high-tech tools like HPLC and spectroscopy, as well as the availability of trained personnel for testing in order to produce accurate results, are additional benefits of drug testing laboratories. In comparison to rapid tests, laboratories therefore provide test results with greater sensitivity and specificity.
NORTH AMERICA DRUG TESTING MARKET BY COUNTRY
The North America Drug Testing market is studied for the following countries
- United States
- Canada
- Mexico
The North American market's dominance is attributed to factors such as growing illicit drug consumption, the allocation of government funding to combat drug abuse, laws supporting drug testing, the rising burden of accidents caused by alcohol impairment, and the presence of key players in the region, all of which are driving the growth of the drug testing market in this region. Further, various government initiatives to monitor and combat substance abuse are driving the market. Health Canada's Substance Use and Addictions Program (SUAP) offers funding and contributions for projects that address substance abuse problems in Canada. This initiative supports substance use prevention, harm reduction, and treatment initiatives across Canada. Moreover, the high adoption of technologically advanced solutions in the region have further supported the market’s growth.
COVID-19 IMPACT ANALYSIS ON NORTH AMERICA DRUG TESTING MARKET
Axiom MRC provides a 360-degree analysis of micro and macro-economic factors on the North America drug testing market. In addition, a complete analysis of changes on the North America drug testing market expenditure, economic and international policies on supply and demand side is provided in this exclusive report. The report also studies the impact of pandemic on North America economies, international trade, business investments, and GDP and marketing strategies of key players present in the market.
COVID-19 has caused significant disruptions to businesses and economies activities around the world and is expected to negatively impact the drug testing market in the short term due to the limited or unavailability of medical facilities/ care centre, suppliers harm reduction services and infection transmission concerns. To ease the pressure on the healthcare system and reduce disease transmission, several governments around the world have issues guideline to delay or delay nonessential medical and surgical procedures. Restrictions and blocks were also imposed on travel, commercial activities, public gatherings and on-site orders, which further influenced market growth. Several countries around the world that have announced nationwide closures and temporary closures of industries, manufacturing, manufacturing and business development have been hit hard.
COMPETITIVE LANDSCAPE ANALYSIS
The competitive landscape analysis of Drug Testing Market is majority focused on expanding the growth of drug testing with new product innovation, business expansion, increasing presence of key players operating in Drug Testing industry has led to the growing demand for the market. Besides, the market offers a range of testing services in different applications to fulfil the required demand of consumers, which further contributes healthy growth in the market.
The key players studied in market are
- Abbott Laboratories
- Thermo Fisher Scientific, Inc.
- Biorad Laboratories, Inc.
- Siemens AG
- Hoffmann-La Roche AG
- Quidel Corporation
- Agilent Technologies, Inc.
- Quest Diagnostics Incorporated
- Shimadzu
- LabCorp
- American Bio Medica Corporation
- CareHealth America Corp
- Omega Laboratories, Inc.
- LifeLoc Technologies
- Premier Biotech, Inc.
- Clinical Reference Laboratory
- Cordant Health Solutions
RECENT DEVELOPMENT:
August 2021: Quest Diagnostics and Select Health of South Carolina had entered into an agreement to expand select Health’s laboratory network for its Medicaid and Medicare-Medicaid dual-eligible enrolees and to enhance access to diagnostics information services for members.
